Table 1.
Description of preoperative cohort characteristics, comorbidity, and measures of disease severity in study participants with CRS (n=128)
| Preoperative measures / comorbidity: | Mean [±SD] | Range: [LL - UL] | N (%) |
|---|---|---|---|
| Age (years at enrollment) | 50.8 [±16.4] | [18 – 81] | |
| Male | 55 (43%) | ||
| Female | 73 (57%) | ||
| White / Caucasian | 112 (88%) | ||
| African American | 6 (5%) | ||
| Asian | 7 (6%) | ||
| Hispanic / Latino | 7 (6%) | ||
| Current tobacco use | 4 (3%) | ||
| Asthma | 57 (45%) | ||
| Allergy (mRAST/skin prick confirmed) | 83 (65%) | ||
| Nasal polyposis | 46 (36%) | ||
| Previous endoscopic sinus surgery | 83 (65%) | ||
| OSA | 9 (7%) | ||
| AERD | 11 (9%) | ||
| Ciliary dyskinesia / CF | 6 (5%) | ||
| Septal deviation | 35 (27%) | ||
| Turbinate hypertrophy | 16 (13%) | ||
| Depression | 16 (13%) | ||
| Corticosteroid dependency | 15 (12%) | ||
| Diabetes mellitus (Type I / II) | 16 (12%) | ||
| GERD | 40 (31%) | ||
| CT total score | 11.8 [±6.3] | [0 – 24] | |
| Endoscopy total score | 5.7 [±3.7] | [0 – 18] |
SD, standard deviation; LL, lower limit; UL, upper limit; OSA, obstructive sleep apnea; AERD, aspiring exacerbated respiratory disease; CF, cystic fibrosis; mRAST, modified radioallergosorbent testing; GERD, gastroesophageal reflux disease; CT, computed tomography; QOD-NS, Questionnaire for Olfactory Disorders, Negative Statements; CRS, chronic rhinosinusitis.